RGC

Regencell Bioscience Holdings
D

RGC

4.17000
USD
-0.19
(-4.36%)
Market Closed
Last updated: · Delayed 15 min
Volume
3,139
EPS
0
Div Yield
-
P/E
-176
Market Cap
2,067,837,848
Related Instruments

Title: Regencell Bioscience Holdings Limited

Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Regencell Bioscience Holdings Ltd is an early-stage bioscience company that focuses on research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degeneration, specifically ADHD and ASD. Its goal is to save and improve the lives of patients, their families and caregivers and become a market leader for the natural and holistic treatment globally. The company operates and manages its business as a single segment - in the research and development of the company's product candidates.

Common questions about Regencell Bioscience Holdings stock